FDA Seizes Paxil CR® and Avandamet®

March 14, 2005 - On March 9, 2005, the FDA seized Paxil CR® and Avandamet® tablets from several GlaxoSmithKline facilities, due to manufacturing problems. The FDA did say that they believe that there is not a significant danger to patients taking either drug. But, violations in manufacturing standards may have resulted in the production of poor-quality drug products that could potentially pose a risk to patients. Avandia®, Paroxetine and Metformin are still available.

The FDA has determined that neither product is medically necessary and that alternative products are available for consumer use. Patients taking either product should discuss possible alternatives with their Physician.